VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > time line

<< Previous

Bullboard Posts

Next >>

Post by bluemoons20on Dec 06, 2021 3:41pm

227 Views

Post# 34203502

time line

All of this 'good' news seems to be being read by the market as an indication that the timeline to buyout is not 'right around the corner'.

there is a lot more work to be done to get this to a stage that it might be adopted. Hence, every day , even good news leads to a drop in price from folks leaving to take up other more timely opportunities.

they may come back after more development, but for now , it looks like they are deserting the ship.

Anyone have any other ideas??

GLTA

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages